The latest cancer drugs news
Browsing: Cancer Drug News
FDA approves niraparib for first-line maintenance of advanced ovarian cancer
The Food and Drug Administration (FDA) approved niraparib for the maintenance treatment of adult patients…
Major trial shows breast cancer drug can hit prostate cancer Achilles heel
A drug already licensed for the treatment of breast and ovarian cancers is more effective…
New clues about why some metastatic prostate cancers don’t respond to enzalutamide
Over the last decade, enzalutamide and similar drugs have led to significant tumour control and…
New targeted agent produces considerable responses in patients with uterine cancer
In its first clinical trial in patients with a hard-to-treat form of uterine cancer, a…
Combinations of paclitaxel and withaferin A against human non-small cell lung cancer
A paper published in Oncotarget has shown that the sensitivity of H1299 and A549 cells to concomitant…
FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer
The Food and Drug Administration (FDA) granted accelerated approval to sacituzumab govitecan-hziy for adult patients…
Turning on the ‘off switch’ in cancer cells
Scientists have identified the binding pocket for molecules that can stabilise a key braking mechanism…
A new treatment for liver cancer
In the journal Molecular Therapy, Skoltech and MIT researchers have published a new combinatorial therapy for…
FDA approves tucatinib in combination with chemotherapy for patients with HER2-positive metastatic breast cancer
The U.S. Food and Drug Administration (FDA) approved tucatinib in combination with chemotherapy (trastuzumab and capecitabine)…
Cancer drug resistance study raises immune red flags
Sooner or later, most cancer patients develop resistance to the very chemotherapy drugs designed to…